These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16846493)

  • 41. [Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
    Uçar E; Kiliç A; Ceyhan I; Yilmaz S; Kiliç S; Tarhan G; Simşek H; Güllü U; Başustaoğlu AC
    Mikrobiyol Bul; 2010 Jan; 44(1):11-9. PubMed ID: 20455394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the microscopic observational drug susceptibility assay for rapid and efficient diagnosis of multi-drug resistant tuberculosis.
    Lazarus RP; Kalaiselvan S; John KR; Michael JS
    Indian J Med Microbiol; 2012; 30(1):64-8. PubMed ID: 22361763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug resistance among Mycobacterium tuberculosis isolates from private clinics and a dots center in Delhi, India.
    Angrup A; Varma-Basil M; Kumar S; Pathak RK; Sharma H; Banavaliker JN; Bose M
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):122-7. PubMed ID: 21323174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.
    Shah NS; Moodley P; Babaria P; Moodley S; Ramtahal M; Richardson J; Heysell S; Li X; Moll A; Friedland G; Sturm AW; Gandhi NR
    Am J Respir Crit Care Med; 2011 May; 183(10):1427-33. PubMed ID: 21297071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
    Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance to first-line tuberculosis drugs in three cities of Nigeria.
    Lawson L; Yassin MA; Abdurrahman ST; Parry CM; Dacombe R; Sogaolu OM; Ebisike JN; Uzoewulu GN; Lawson LO; Emenyonu N; Ouoha JO; David JS; Davies PD; Cuevas LE
    Trop Med Int Health; 2011 Aug; 16(8):974-80. PubMed ID: 21564425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New era in molecular epidemiology of tuberculosis in Japan].
    Takashima T; Iwamoto T
    Kekkaku; 2006 Nov; 81(11):693-707. PubMed ID: 17154049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan.
    Hofmann-Thiel S; van Ingen J; Feldmann K; Turaev L; Uzakova GT; Murmusaeva G; van Soolingen D; Hoffmann H
    Eur Respir J; 2009 Feb; 33(2):368-74. PubMed ID: 18829680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.
    Frieden TR; Sherman LF; Maw KL; Fujiwara PI; Crawford JT; Nivin B; Sharp V; Hewlett D; Brudney K; Alland D; Kreisworth BN
    JAMA; 1996 Oct; 276(15):1229-35. PubMed ID: 8849750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eleven-year experience on anti-TB drugs direct susceptibility testing from Siriraj Hospital, Thailand.
    Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):241-4. PubMed ID: 23973429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transmission of specific genotype streptomycin resistant strains of Mycobacterium tuberculosis in the Tokyo Metropolitan Area in Japan.
    Ohkado A; Murase Y; Mori M; Hasegawa N; Otsuka G; Nagamine M; Maeda H; Uchimura K; Ohmori M; Yamada N; Maeda S; Kato S; Mori T; Ishikawa N
    BMC Infect Dis; 2009 Aug; 9():138. PubMed ID: 19709409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid diagnosis of Mycobacterium tuberculosis infection and drug susceptibility testing.
    Wilson ML
    Arch Pathol Lab Med; 2013 Jun; 137(6):812-9. PubMed ID: 23721277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug resistant tuberculosis in prisons in Azerbaijan: case study.
    Coninx R; Pfyffer GE; Mathieu C; Savina D; Debacker M; Jafarov F; Jabrailov I; Ismailov A; Mirzoev F; de Haller R; Portaels F
    BMJ; 1998 May; 316(7142):1423-5. PubMed ID: 9572751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isoniazid Monoresistance and Rate of Culture Conversion among Patients in the State of Georgia with Confirmed Tuberculosis, 2009-2014.
    Salindri AD; Sales RF; DiMiceli L; Schechter MC; Kempker RR; Magee MJ
    Ann Am Thorac Soc; 2018 Mar; 15(3):331-340. PubMed ID: 29131662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary drug resistance and molecular epidemiology of Mycobacterium tuberculosis isolates from patients in a population with high tuberculosis incidence in Turkey.
    Durmaz R; Ozerol IH; Durmaz B; Gunal S; Senoglu A; Evliyaoglu E
    Microb Drug Resist; 2003; 9(4):361-6. PubMed ID: 15000742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug susceptibility profiles of Mycobacterium tuberculosis isolates at Mangalore.
    Bhat S; Radhakrishna M; Kotian M; Rao S
    Indian J Med Sci; 2010 Mar; 64(3):99-103. PubMed ID: 22569321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tuberculosis cases in a prison in the extreme south of Brazil.
    Venske Bierhals D; Busatto C; Silveira MDPDR; da Matta Talaier E; Silva ABS; Reis AJ; von Groll A; da Silva PEA; Ramis IB
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33555247
    [No Abstract]   [Full Text] [Related]  

  • 59. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
    Coninx R; Mathieu C; Debacker M; Mirzoev F; Ismaelov A; de Haller R; Meddings DR
    Lancet; 1999 Mar; 353(9157):969-73. PubMed ID: 10459906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular epidemiology of Mycobacterium tuberculosis strains circulating in the penitentiary system of Kazakhstan.
    Ibrayeva A; Kozhamkulov U; Raiymbek D; Alenova A; Igilikova S; Zholdybayeva E; Abildaev T; Momynaliev K
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):298-301. PubMed ID: 24670565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.